EP2934509
TASIMELTEON FOR THE TREATMENT OF CIRCADIAN RHYTHM DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.12.2013EP published:
27.5.2020EP application number:
13817826.4
EPO information:
European Patent Register
Max expiry date:
17.12.2033
Title:
TASIMELTEON FOR THE TREATMENT OF CIRCADIAN RHYTHM DISORDERS
Timeline
Today
18.12.2013EP application
27.5.2020EP Publication
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
2200 Pennsylvania Avenue NW Suite 300, Washington, DC 20037, US
Inventor
Name:
DRESSMAN, Marlene MichelleAddress:
Germantown, MD 20874, US
Name:
FEENEY, John JosephAddress:
Olney, MD 20832, US
Name:
LICAMELE, Louis WilliamAddress:
Potomac, MD 20854, US
Name:
POLYMEROPOULOS, Mihael H.Address:
Potomac, MD 20854, US
Priority
Number:
201261738985 PDate:
18.12.2012Country:
US
Number:
201261738987 PDate:
18.12.2012Country:
US
Number:
201361755896 PDate:
23.1.2013Country:
US
Number:
PCT/US2013/023315Date:
25.1.2013Country:
WO
Number:
201313751011Date:
25.1.2013Country:
US
Number:
201361903354 PDate:
12.11.2013Country:
US
Classification
Categories:
A61K 31/343, A61P 5/00, A61P 43/00, A61K 45/06, A61K 31/31, A61K 31/496, G16H 10/60